Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
0.002 USD 0.00(0%)
Last update at 2026-11-20T18:47:00Z
VOLUME
750575
Market Cap
1.42M

Momentum Score

…

CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Germany, Israel, Portugal, and Canada. It produces and sells dried cannabis flower and trim shake, as well as unique genetics, medical cannabis, and craft products. The company is based in Cremona, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

CannaPharmaRx, Inc. (CPMD) is a microcap issuer quoted on the OTC Pink market that identifies itself in public filings as operating in the cannabis/cannabinoid sector, but public disclosures are limited. Long-term growth could be supported by broader legalization trends, expanding consumer acceptance and successful execution on product or distribution initiatives, and the company may benefit if management improves operational transparency.
The primary risk is limited and intermittent public disclosure, thin trading liquidity and substantial regulatory and operational uncertainty in the cannabis sector, which could impair investor visibility and value realization.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
1.70M
Revenue Per Share
0.00
Gross Profit TTM
-1.81M
Debt / Equity
-0.68
ROE
-250.89%
Net Debt
20.65M
ROCE
13.62%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -11.13M -9.91M 3.69M -8.53M -8.83M
Net income -11.13M -9.91M 3.69M -8.53M -10.34M
Selling general administrative 0.96M 0.59M 1.25M 4.91M 2.61M
Selling and marketing expenses - 0.00M 0.10M - -
Gross profit -2.08M -2.94M -0.07M - -0.01M
Reconciled depreciation - 0.00M 0.30M 0.29M 0.00M
Ebit - -7.64M -1.57M -5.21M -2.99M
Ebitda -8.68M -7.64M -1.45M -5.95M -2.61M
Depreciation and amortization - 0.00M 0.13M - 0.38M
Operating income -3.35M -3.61M -1.58M -5.21M -2.99M
Other operating expenses 4.71M 4.43M 1.58M - 2.62M
Interest expense 2.45M 2.26M 1.70M 2.29M 1.51M
Tax provision - - - 0.00M 0.00M
Net interest income -2.45M -2.26M -2.02M -2.29M -1.51M
Income tax expense - - 2.69M - 1.51M
Total revenue 1.36M 0.82M 0.00M 0.00M 0.00M
Total operating expenses 1.26M 0.67M 1.58M 5.21M 2.62M
Cost of revenue 3.45M 3.75M 0.07M - 0.01M
Total other income expense net -7.78M -6.30M 5.27M -1.03M -5.84M
Net income from continuing ops -11.13M -9.91M -7.50M -8.53M -8.83M
Net income applicable to common shares - - - -8.53M -8.83M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 7.02M 10.84M 11.75M 5.41M 0.11M
Other current assets 0.03M 0.02M 0.07M 0.01M 0.00M
Total liab 37.17M 30.65M 23.90M 22.76M 13.04M
Total stockholder equity -30.15M -19.81M -12.15M -17.34M -12.93M
Other current liab 10.79M 12.53M 5.37M 1.20M 0.51M
Common stock 0.07M 0.07M 0.04M 0.03M 0.01M
Capital stock 0.70M 0.70M 3.33M 2.59M 0.55M
Retained earnings -112.32M -101.18M -91.28M -94.70M -86.16M
Other liab - - - - -0.00M
Other assets - - 0.00M - -
Cash 0.00M 0.00M 0.00M 0.00M 0.03M
Total current liabilities 31.59M 25.75M 18.16M 17.17M 13.04M
Current deferred revenue 0.26M - 0.34M - 0.38M
Net debt 20.65M 14.06M 12.93M 8.93M 8.99M
Short term debt 15.07M 8.44M 7.20M - 9.02M
Short long term debt 14.07M 8.44M 7.01M 8.93M 9.02M
Short long term debt total 20.65M 14.06M 12.94M - 9.02M
Other stockholder equity 81.52M 80.68M 75.83M 0.24M 73.06M
Property plant equipment - - - 5.24M 0.01M
Total current assets 1.31M 1.02M 1.20M 0.10M 0.03M
Long term investments 0.00M 4.52M 4.52M 0.08M 0.08M
Net tangible assets - - - -19.90M -13.47M
Net receivables 0.16M 0.02M 0.06M 0.02M 0.00M
Long term debt 0.55M - - - -
Inventory 1.12M 1.00M 1.13M - -0.00M
Accounts payable 5.47M 4.78M 5.59M 6.88M 3.13M
Accumulated other comprehensive income -0.06M 0.56M -0.04M - -0.37M
Non currrent assets other 5.71M 5.30M -0.00M - 0.01M
Non current assets total 5.71M 9.82M 10.55M 5.31M 0.08M
Capital lease obligations 6.03M 5.62M 5.93M 5.59M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M -0.09M -0.12M 0.49M
Change to liabilities - - - 1.42M -0.45M
Total cashflows from investing activities -0.01M - -0.08M -0.12M 0.53M
Net borrowings 0.79M 1.70M 2.35M 0.97M 0.51M
Total cash from financing activities 0.79M 1.70M 2.35M 1.40M 1.34M
Change to operating activities - - - 2.53M 0.03M
Net income -11.13M -9.91M 3.69M -8.53M -8.83M
Change in cash -0.00M 0.00M -0.00M -0.03M -0.31M
Begin period cash flow 0.00M 0.00M 0.00M 0.03M 0.33M
End period cash flow 0.00M 0.00M 0.00M 0.00M 0.03M
Total cash from operating activities -0.79M -1.70M -2.27M -1.45M -2.41M
Issuance of capital stock - - -0.06M 0.44M 0.83M
Depreciation - 0.00M 0.13M 0.29M 0.00M
Other cashflows from investing activities -0.01M - - - -
Change to inventory -1.99M -0.51M -1.13M - -
Change to account receivables -1.02M -0.00M -0.04M - -
Other cashflows from financing activities 0.79M 1.70M 2.35M - 1.36M
Change to netincome - - - 2.36M 5.58M
Capital expenditures 0.01M 0.00M 0.08M 0.12M 0.01M
Change in working capital 0.43M 0.02M -0.82M 3.95M -0.42M
Stock based compensation 0.14M 0.00M 0.18M 0.18M 0.36M
Other non cash items 9.91M 8.18M -5.27M 1.23M 1.52M
Free cash flow -0.79M -1.70M -2.36M -1.56M -2.42M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CPMD
CannaPharmaRx Inc
-
-%
0.00 - - 0.83 11.05 13.35 6.69
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16 2.94 23.11

Profile*

CannaPharmaRx Inc

CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Germany, Israel, Portugal, and Canada. It produces and sells dried cannabis flower and trim shake, as well as unique genetics, medical cannabis, and craft products. The company is based in Cremona, Canada.

4439 Township Rd 304, Cremona, AB, Canada, T0M 0R0

403 637 0420

26

Name Title Year Born
Mr. Dominick Colvin CEO, Pres & Director 1968
Mr. John Hamilton Cassels C.A., CPA CFO & Sec. 1948
Mr. Andrew Clifford Steedman Chief Operations Officer 1961
Mr. Constantine Nkafu Interim CEO & Director 1976
Mr. Oliver W. Foeste C.A., CPA Chief Financial Officer 1977
Mr. Constantine Nkafu CEO & Director 1976
Mr. Oliver W. Foeste C.A., CPA Chief Financial Officer 1976

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…